犬细小病毒NY株VP2蛋白多克隆抗体的制备与鉴定
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Preparation and Identification of Canine Parvovirus NY Strain VP2 Protein Polyclonal Antibody
  • 作者:毛倩倩 ; 周灵 ; 唐青海 ; 卜宾 ; 唐存多 ; 焦铸锦 ; 姚伦广 ; 阚云超 ; 杨建伟 ; 崔尚金
  • 英文作者:MAO Qian-qian;ZHOU Ling;TANG Qing-hai;BU Bin;TANG Cun-duo;JIAO Zhu-jin;YAO Lun-guang;KAN Yun-chao;YANG Jian-wei;CUI Shang-jin;Center for Nanyang Veterinary Biological Engineering Technology,Henan Provincial Engineering Laboratory of Insect Bio-reactor,Henan Provincial Key Laboratory of Insect Biology in Funiu Moutain,Nanyang Normal University;Animal Science and Technology College,Jilin Agricultural University;Institute of Animal Sciences,Chinese Academy of Agricultural Sciences;
  • 关键词:犬细小病毒 ; VP2基因 ; 多克隆抗体 ; 免疫活性
  • 英文关键词:caine parvirus;;VP2 gene;;polyclonal antibody;;immunocompetence
  • 中文刊名:GWXK
  • 英文刊名:China Animal Husbandry & Veterinary Medicine
  • 机构:南阳师范学院南阳市兽医生物工程技术研究中心河南省伏牛山昆虫生物学重点实验室昆虫生物反应器河南省工程实验室;吉林农业大学动物科学技术学院;中国农业科学院北京畜牧兽医研究所;
  • 出版日期:2016-07-20
  • 出版单位:中国畜牧兽医
  • 年:2016
  • 期:v.43;No.320
  • 基金:河南省重点科技攻关项目(142102110101);; 河南省高等学校重点科研项目(16A230023);; 南阳师范学院引进人才专项项目(70640)
  • 语种:中文;
  • 页:GWXK201607001
  • 页数:8
  • CN:07
  • ISSN:11-4843/S
  • 分类号:8-15
摘要
试验旨在制备犬细小病毒(canine parvovirus,CPV)VP2蛋白多克隆抗体。构建pET28a-CPV-VP2重组表达质粒转化大肠杆菌BL21(DE3)感受态细胞,经IPTG诱导,SDS-PAGE鉴定融合蛋白的表达,纯化目的蛋白与佐剂混合、乳化制备后作为免疫原,免疫家兔制备VP2蛋白多克隆抗体;采用免疫过氧化物酶单层细胞染色法(immunoperoxidase monolayer assay,IPMA)检测抗体的免疫活性、抗体滴度、病毒滴度及中和活性。结果表明,重组VP2蛋白(rVP2)以包涵体形式存在,分子质量约为72ku;所制备的多克隆抗体滴度为1 600倍,病毒滴度为107 TCID50/mL,中和效价为1∶2 884,该抗体与体外培养的CPV呈特异性反应,CPV VP2蛋白的多克隆抗体免疫活性和特异性良好,且中和活性高,为CPV基因工程疫苗的研究和临床治疗奠定了基础。
        This study was aimed to prepare canine parvovirus(CPV)VP2protein polyclonal antibody.The recombinant expression vector pET28a-CPV-VP2 was constructed and transfromed into E.coli BL21(DE3),the expression of recombinant proteins was induced by IPTG from which the fusion protein was identified by SDS-PAGE.The target protein was purified and emulsify with adjuvant,the prepared immunogen was inoculated into rabbit by subcutaneous injections to prepare of VP2 protein specific polyclonal antibody.The immuno-activity,titers,neutralization titers of the prepared polyclonal antibody were determined by immunoperoxidase monolayer assay(IPMA).The results showed that the expressed recombinant protein VP2(rVP2)existed in the form of inclusion body with a molecular weight of 72 ku.The prepared polyclonal antibody titerwas 1 600 dilution,the virus titer was 107 TCID50/mL,the neutralizing titer was 1∶2 884.The antibodies showed specific reaction with CPV.In conclusion,rVP2 specific polyclonal antibody showed wonderful immunocompetence,specificity and neutralizing activity,providing foundation for the development of genetic vaccine and clinical therapeutic method.
引文
[1]刘静,赵学刚,陆江,等.犬细小病毒流行病学调查[J].中国畜牧兽医,2013,40(3):199-201.
    [2]Welborn L V,DeVries J G,Ford R,et al.2011AAHA canine vaccination guidelines[J].J Am Anim Hosp Assoc,2011,47(5):1-42.
    [3]Apple M J,Scott F W,Carmichael L E.Isolation and immunisation studies of a caine parco-like virus from dogs with haemorrhagic enteritis[J].Vet Rec,1979,105(8):156-159.
    [4]Truyen U,Evermann J F,Vieler E,et al.Evolution of canine parvovirus involved loss and gain of feline host range[J].Virology,1996,215(2):186-189.
    [5]Parrish C R,Aquadro C F,Strassheim M L,et al.Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus[J].J Virol,1991,65(12):6544-6552.
    [6]Buonavoglia C,Martella V,Pratelli A,et al.Evidence for evolution of canine parvovirus type 2in Italy[J].J Gen Virol,2001,82(12):3021-3025.
    [7]Decaro N,Desario C,Billi M,et al.Western European epidemiological survey for parvovirus and coronavirus infections in dogs[J].Vet J,2011,187(2):195-199.
    [8]Touihri L,Bouzid I,Daoud R,et al.Molecular characterization of canine parvovirus-2variants circulating in Tunisia[J].Virus Genes,2009,38(2):249-258.
    [9]Nakamura M,Tohya Y,Miyazawa T,et al.A novel antigenic variant of canine parvovirus from a Vietnamese dog[J].Arch Virol,2004,149(11):2261-2269.
    [10]Hong C,Decaro N,Desario C,et al.Occurrence of canine parvovirus type 2cin the United States[J].J Vet Diagn Invest,2007,19(5):535-539.
    [11]Perez R,Francia L,Romero V.First detection of canine parvovirus type 2cin South America[J].Veterinary Microbiology,2007,124:147-152.
    [12]Geng Y F,Guo D H,Li C Q,et al.Co-circulation of the rare CPV-2cwith unique Gln370Ala substitution,abd new CPV-2awith high prevalence and variation in Heilongjiang province,Northeast China[J].PLoS One,2016,10(9):e0137288.
    [13]Parker J S,Murphy W J,Wang D.Canine and feline parvoviruses can use human or feline transferrin receptors to bind enter and infect cells[J].J Virol,2001,75(8):3896-3902.
    [14]Hueffer K,Palermo L M,Parrish C R.Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis,membrane domain localization,and capsid-binding domains[J].J Virol,2004,78(11):5601-5611.
    [15]Hueffer K,Govindasamy L,Agbandje M.Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses[J].Virology,2003,77(18):10099-10105.
    [16]Jeoung S Y,Ahn S J,Kim H.Genetic analysis of VP2gene of canine parvovirus isolates in Korea[J].J Vet Med Science,2008,70:719-722.
    [17]刘杉杉,赵亚荣,张超范,等.猪细小病毒抗体IPMA检测方法的建立及应用[J].中国兽医科学,2011,41(4):387-391.
    [18]Direksin K,Joo H,Goyal S M.An immunoperoxidase monolayer assay for the detection of antibodies against swine influenza virus[J].J Vet Diagn Invest,2002,14(2):169-171.
    [19]Streck A F,Ruster D,Truyen U.An updated TaqMan Real-time PCR for canine and feline parvoviruses[J].Journal of Virological Methods,2013,193(1):6-8.
    [20]张立媛.犬细小病毒YBYJ株的分离鉴定及VP2基因克隆与多克隆抗体的制备[D].延边:延边大学,2015.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.